Lateral meningocele syndrome

Last updated
Lateral meningocele syndrome
Other namesLehman syndrome [1]
Autosomal dominant - en.svg
Lateral meningocele syndrome is inherited in an autosomal dominant manner

Lateral meningocele syndrome, also known as Lehman syndrome, [2] is a very rare skeletal disorder with facial anomalies, hypotonia, and meningocele-related neurologic dysfunction. [3] These protrusions form from membranes surrounding the spinal cord in gaps in the spine (vertebrae). [4] They most often occur in the lower spine and damage the surrounding nerves that spread throughout the rest of the body. [4] Examples of resulting damages are bladder function, prickling or tingling sensations, stiffness and weakness in the legs, and back pain. [4] People affected with lateral meningocele typically have high arched eyebrows, widely spaced eyes, droopy eyes, and other facial features. There have been only 14 reported individuals with lateral meningocele syndrome with 7 of those who have a molecularly confirmed diagnosis. [5] There is no specific treatment for this syndrome, but only supportive management including lateral spinal meningoceles, psychomotor development, musculoskeletal, and routine management. [5]

Contents

Signs and Symptoms

Facial features found in this syndrome include [6]

Non facial features of this syndrome include [6]

This syndrome also leads to a delayed development of motor skills in infancy, including sitting and crawling. Intelligence, however, usually stays unaffected. [6] Some other features of this syndrome are low muscle tone during infancy, decreased muscle bulk, loose joints, and hernias. [6]

Diagnosis is based on a presentation concurrent with previous clinical reports, as well as a heterozygous pathogenic variant in the NOTCH3 gene. [5]

Diagnosis

Diagnosis of Lehman syndrome may be suspected based on several distinctive facial features, the presence of lateral meningoceles, hyperextensibility, and hypotonia. [7] Aside from physical presence, radiographic images of the spine may also clinically diagnose lateral meningoceles. With molecular genetic testing, Lehman syndrome is positively identified with the presence of a pathogenic variant in NOTCH3. [5] When the disorder was initially discovered, features of maldevelopment of the spinal cord, cerebellum, and cerebral cortex distinguished the diagnosis of Lehman syndrome. [8] Among all historical cases (from the period 1997-2015), patients were diagnosed with disorder before the age of 20 years old and as early as 5 years old. [9] [7]

Treatment

Currently, there is no treatment for Lehman syndrome. The only suggestions for patients with this disorder is to manage any of the associated symptoms. [5] For instance, pain management options are present for those experiencing chronic pain. Under rare circumstances, surgical intervention is required for neurologic manifestations. Further, some patient benefit from rehabilitation medicine, physiotherapy, as well as routine management of cleft palate, hearing loss, congenital cardiac defects, genitourinary abnormalities, and feeding difficulties. [5]

History

This syndrome was first described by Lehman et al. in 1977. [10] This paper described a 14-year-old girl with a number of unusual findings. Her mother shared some of the same findings. Since then over a dozen additional cases have been reported.

Genetics

This syndrome appears to be inherited in an autosomal dominant fashion; however, X-linked inheritance has not been completely ruled out. [11] Males diagnosed with Lehman syndrome were effected the same as females causing the believed inheritance pattern to be autosomal dominant, not X-linked. [6]

Lehman syndrome is associated with the heterozygous truncating mutation on exon33 of the Notch 3 gene located on chromosome 19p13. [6] The mutation was found using whole-exome sequencing and confirmed with Sanger sequencing.

Molecular analyses suggest that the causative mutations cause a truncation of the protein. These mutations result in the loss of PEST sequence in the protein. This loss is associated with a prolonged half life of the protein and therefore an increase in signaling effects. [6]

Mutations in Notch 3 were found to be associated with this syndrome. [6] Notch 3 produces the Notch 3 protein, [12] a receptor protein in which ligands bind to control gene activity in a cell's nucleus. The Notch 3 gene is a part of the Notch family of genes which are associated with cell differentiation and function. [13] The Notch 3 mutation is a truncating mutation because it results in the loss of the intracellular end of the Notch 3 protein known as the Notch 3 intracellular domain, NICD. [12] This section of the truncated NCID is responsible for disintegration of the NCID after it has gone into the nucleus and completed its function. [4] The mutation causes the Notch 3 protein to be in the cell nucleus for a prolonged period of time continuing to affect gene activity. [12]

Epidemiology

This genetic disease in very rare. There have been 16 reported cases in 14 different families. [4] 9 cases were male patients and 7 cases were female patients. [4]

Inheritance of Lehman syndrome from a parent has occurred. However de novo mutations of the Notch 3 gene are more common. [4]

There is no prevalence in specific populations. [5]

Related Research Articles

<span class="mw-page-title-main">Kabuki syndrome</span> Medical condition

Kabuki syndrome is a rare congenital disorder of genetic origin. It affects multiple parts of the body, with varying symptoms and severity, although the most common is the characteristic facial appearance.

<span class="mw-page-title-main">Immunodeficiency–centromeric instability–facial anomalies syndrome</span> Medical condition

ICF syndrome is a very rare autosomal recessive immune disorder.

<span class="mw-page-title-main">Alagille syndrome</span> Medical condition

Alagille syndrome (ALGS) is a genetic disorder that affects primarily the liver and the heart. Problems associated with the disorder generally become evident in infancy or early childhood. The disorder is inherited in an autosomal dominant pattern, and the estimated prevalence of Alagille syndrome is 1 in every 30,000 to 1 in every 40,000 live births. It is named after the French pediatrician Daniel Alagille, who first described the condition in 1969.

<span class="mw-page-title-main">Rubinstein–Taybi syndrome</span> Rare genetic condition

Rubinstein–Taybi syndrome (RTS) is a rare genetic condition characterized by short stature, moderate to severe learning difficulties, distinctive facial features, and broad thumbs and first toes. Other features of the disorder vary among affected individuals. These characteristics are caused by a mutation or deletion in the CREBBP gene, located on chromosome 16, and/or the EP300 gene, located on chromosome 22.

<span class="mw-page-title-main">Congenital muscular dystrophy</span> Medical condition

Congenital muscular dystrophies are autosomal recessively-inherited muscle diseases. They are a group of heterogeneous disorders characterized by muscle weakness which is present at birth and the different changes on muscle biopsy that ranges from myopathic to overtly dystrophic due to the age at which the biopsy takes place.

Abruzzo–Erickson syndrome is an extremely rare disorder characterized by deafness, protruding ears, coloboma, a cleft palate or palatal rugosity, radial synostosis, and short stature. It was first characterized by Abruzzo and Erickson in 1977 as a CHARGE like syndrome as variably expressed among a family of two brothers, their mother, and their maternal uncle. Members of this family exhibited many of the CHARGE symptoms, but notably did not have choanal atresia and the brothers experienced typical genital development. Due to the recent discovery of this disorder, its etiology is not fully known but it is understood that it arises from mutations on the TBX22 gene on the X-chromosome. The disorder is inherited in an X-linked recessive manner. There is currently no known cure but its symptoms can be treated.

<span class="mw-page-title-main">NOTCH3</span> Protein-coding gene in the species Homo sapiens

Neurogenic locus notch homolog protein 3(Notch 3) is a protein that in humans is encoded by the NOTCH3 gene.

<span class="mw-page-title-main">Young–Simpson syndrome</span> Medical condition

Young–Simpson syndrome (YSS) is a rare congenital disorder with symptoms including hypothyroidism, heart defects, facial dysmorphism, cryptorchidism in males, hypotonia, intellectual disability, and postnatal growth retardation.

Vici syndrome, also called immunodeficiency with cleft lip/palate, cataract, hypopigmentation and absent corpus callosum, is a rare autosomal recessive congenital disorder characterized by albinism, agenesis of the corpus callosum, cataracts, cardiomyopathy, severe psychomotor retardation, seizures, immunodeficiency and recurrent severe infections. To date, about 50 cases have been reported.

<span class="mw-page-title-main">Marshall syndrome</span> Medical condition

Marshall syndrome is a genetic disorder of the connective tissue that can cause hearing loss. The three most common areas to be affected are the eyes, which are uncommonly large, joints and the mouth and facial structures. Marshall syndrome and Stickler syndrome closely resemble each other; in fact they are so similar, some say they are the same. The condition is named for D. Weber.

Malpuech facial clefting syndrome, also called Malpuech syndrome or Gypsy type facial clefting syndrome, is a rare congenital syndrome. It is characterized by facial clefting, a caudal appendage, growth deficiency, intellectual and developmental disability, and abnormalities of the renal system (kidneys) and the male genitalia. Abnormalities of the heart, and other skeletal malformations may also be present. The syndrome was initially described by Georges Malpuech and associates in 1983. It is thought to be genetically related to Juberg-Hayward syndrome. Malpuech syndrome has also been considered as part of a spectrum of congenital genetic disorders associated with similar facial, urogenital and skeletal anomalies. Termed "3MC syndrome", this proposed spectrum includes Malpuech, Michels and Mingarelli-Carnevale (OSA) syndromes. Mutations in the COLLEC11 and MASP1 genes are believed to be a cause of these syndromes. The incidence of Malpuech syndrome is unknown. The pattern of inheritance is autosomal recessive, which means a defective (mutated) gene associated with the syndrome is located on an autosome, and the syndrome occurs when two copies of this defective gene are inherited.

<span class="mw-page-title-main">Floating–Harbor syndrome</span> Medical condition

Floating–Harbor syndrome, also known as Pelletier–Leisti syndrome, is a rare disease with fewer than 50 cases described in the literature. It is usually diagnosed in early childhood and is characterized by the triad of proportionate short stature with delayed bone age, characteristic facial appearance, and delayed speech development. Although its cause is unknown, it is thought to result from genetic mutation, and diagnosis is established by the presence of a heterozygous SRCAP mutation in those with clinical findings of FHS.

AHDC1 is a gene, changes in which are found through clinical studies to cause an array of symptoms in affected children known collectively as Xia-Gibbs Syndrome, including global developmental delay, global hypotonia, obstructive sleep apnoea and seizures.

Xia-Gibbs syndrome, is genetic disorder caused by a heterozygous mutation in the AHDC1 gene on chromosome 1p36.

ZTTK syndrome is a rare multisystem disease caused in humans by a genetic mutation of the SON gene. Common symptoms include developmental delay and often mild to severe intellectual disability.

<span class="mw-page-title-main">Bainbridge–Ropers syndrome</span> Human genetic disorder

Bainbridge–Ropers syndrome was first identified in 2013 and is characterized by failure to thrive, feeding problems, hypotonia, intellectual disabilities, autism, postnatal growth delay, abnormal facial features such as arched eyebrows, anteverted nares, and delays in language acquisition. BRPS is extremely rare worldwide; more than thirty cases of BRPS have been reported abroad, and four cases have been reported in China.

DeSanto-Shinawi (DESSH) syndrome is a rare genetic disorder caused by genetic variations (mutations) in a gene called WW Domain-Containing Adaptor with Coiled-coil Region. The condition was first described in 2015 in six individuals. The prevalence of DESSH syndrome is unknown at this time, but 25 individuals have been so far described in the medical literature. However, many other individuals with this condition are being studied and characterized. With the increasing utilization of exome and whole genome sequencing, it is anticipated that many more individuals to be identified.

Dysosteosclerosis (DSS), also known as autosomal recessive dysosteosclerosis or X-linked recessive dysosteosclerosis, is a rare osteoclast-poor form of osteosclerosis that is presented during infancy and early childhood, characterized by progressive osteosclerosis and platyspondyly. Platyspondyly and other skeletal abnormalities are radiographic features of the disease which distinguish DSS from other osteosclerotic disorders. Patients usually experience neurological and psychological deterioration, therefore patients are commonly associated with delayed milestones.

CHAMP1-associated intellectual disability syndrome, also known as autosomal dominant intellectual disability type 40, is a rare genetic disorder characterized by intellectual disabilities, developmental delays, facial dysmorphisms, and other anomalies.

<span class="mw-page-title-main">Severe intellectual disability-progressive spastic diplegia syndrome</span> Medical condition

Severe intellectual disability-progressive spastic diplegia syndrome is a rare novel genetic disorder characterized by severe intellectual disabilities, ataxia, craniofacial dysmorphisms, and muscle spasticity. It is a type of autosomal dominant syndromic intellectual disability.

References

  1. ↑ "Lateral meningocele syndrome". Orphanet. Retrieved 20 October 2019.
  2. ↑ "Lehman syndrome". Orphanet. Retrieved 2021-04-21.
  3. ↑ James L. Frasier; George I. Jallo (2008). "Anterior and Lateral Meningoceles". In M. Memet Özek; Giuseppe Cinalli; Wirginia J. Maixner (eds.). Spina bifida : management and outcome. Milan: Springer. p. 432. ISBN   9788847006508.
  4. 1 2 3 4 5 6 7 "Lateral meningocele syndrome: MedlinePlus Genetics". medlineplus.gov. Retrieved 2022-03-17.
  5. 1 2 3 4 5 6 7 Ejaz, Resham; Carter, Melissa; Gripp, Karen (1993). "NOTCH3-Related Lateral Meningocele Syndrome". In Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.). Lateral Meningocele Syndrome. GeneReviews. Seattle, WA: University of Washington, Seattle. PMID   27336130 . Retrieved 2021-04-21.
  6. 1 2 3 4 5 6 7 8 "OMIM Entry - # 130720 - LATERAL MENINGOCELE SYNDROME; LMNS". www.omim.org. Retrieved 2022-03-17.
  7. 1 2 Gripp, Karen W.; Robbins, Katherine M.; Sobreira, Nara L.; Witmer, P. Dane; Bird, Lynne M.; Avela, Kristiina; Makitie, Outi; Alves, Daniela; Hogue, Jacob S.; Zackai, Elaine H.; Doheny, Kimberly F. (February 2015). "Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome". American Journal of Medical Genetics. Part A. 167A (2): 271–281. doi:10.1002/ajmg.a.36863. ISSN   1552-4833. PMC   5589071 . PMID   25394726.
  8. ↑ Lehman, R. A.; Stears, J. C.; Wesenberg, R. L.; Nusbaum, E. D. (January 1977). "Familial osteosclerosis with abnormalities of the nervous system and meninges". The Journal of Pediatrics. 90 (1): 49–54. doi:10.1016/s0022-3476(77)80763-4. ISSN   0022-3476. PMID   830893.
  9. ↑ Philip, N.; Andrac, L.; Moncla, A.; Sigaudy, S.; Zanon, N.; Lena, G.; Choux, M. (October 1995). "Multiple lateral meningoceles, distinctive facies and skeletal anomalies: a new case of Lehman syndrome". Clinical Dysmorphology. 4 (4): 347–351. doi:10.1097/00019605-199510000-00011. ISSN   0962-8827. PMID   8574426. S2CID   1687286.
  10. ↑ Lehman RAW, Stears JC, Wesenberg RL, Nusbaum ED (1977) Familial osteosclerosis with abnormalities of the nervous system and meninges. J Pediat 90: 49-54
  11. ↑ "OMIM Entry - # 130720 - LATERAL MENINGOCELE SYNDROME; LMNS". www.omim.org. Retrieved 2022-03-18.
  12. 1 2 3 "Lateral meningocele syndrome: MedlinePlus Genetics". medlineplus.gov. Retrieved 2022-03-18.
  13. ↑ Canalis, Ernesto (2020). "The Skeleton of Lateral Meningocele Syndrome". Frontiers in Genetics. 11: 620334. doi: 10.3389/fgene.2020.620334 . ISSN   1664-8021. PMC   7841456 . PMID   33519922.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.